Collier AC - Search Results

1

The safety and efficacy of combination N-butyl-deoxynojirimycin (SC-48334) and zidovudine in patients with HIV-1 infection and 200-500 CD4 cells/mm3.

Fischl MA, Resnick L, Coombs R, Kremer AB, Pottage JC Jr, Fass RJ, Fife KH, Powderly WG, Collier AC, Aspinall RL, et al. Fischl MA, et al. Among authors: collier ac. J Acquir Immune Defic Syndr (1988). 1994 Feb;7(2):139-47. J Acquir Immune Defic Syndr (1988). 1994. PMID: 7905523 Clinical Trial.

2

Combination and monotherapy with zidovudine and zalcitabine in patients with advanced HIV disease. The NIAID AIDS Clinical Trials Group.

Fischl MA, Stanley K, Collier AC, Arduino JM, Stein DS, Feinberg JE, Allan JD, Goldsmith JC, Powderly WG. Fischl MA, et al. Among authors: collier ac. Ann Intern Med. 1995 Jan 1;122(1):24-32. doi: 10.7326/0003-4819-122-1-199501010-00004. Ann Intern Med. 1995. PMID: 7985892 Clinical Trial.

3

The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group.

Fischl MA, Richman DD, Hansen N, Collier AC, Carey JT, Para MF, Hardy WD, Dolin R, Powderly WG, Allan JD, et al. Fischl MA, et al. Among authors: collier ac. Ann Intern Med. 1990 May 15;112(10):727-37. doi: 10.7326/0003-4819-112-10-727. Ann Intern Med. 1990. PMID: 1970466 Clinical Trial.

4

Phase 1 study of combination therapy with L-697,661 and zidovudine. The ACTG 184 Protocol Team.

Schooley RT, Campbell TB, Kuritzkes DR, Blaschke T, Stein DS, Rosandich ME, Phair J, Pottage JC, Messari F, Collier A, Kahn J. Schooley RT, et al. J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Aug 1;12(4):363-70. doi: 10.1097/00042560-199608010-00006. J Acquir Immune Defic Syndr Hum Retrovirol. 1996. PMID: 8673545 Clinical Trial.

5

Safety, pharmacokinetics, and antiviral response of CD4-immunoglobulin G by intravenous bolus in AIDS and AIDS-related complex.

Collier AC, Coombs RW, Katzenstein D, Holodniy M, Gibson J, Mordenti J, Izu AE, Duliege AM, Ammann AJ, Merigan T, et al. Collier AC, et al. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Oct 1;10(2):150-6. doi: 10.1097/00042560-199510020-00006. J Acquir Immune Defic Syndr Hum Retrovirol. 1995. PMID: 7552478 Clinical Trial.

6

Phase I study of high-dose, intravenous rsCD4 in subjects with advanced HIV-1 infection.

Schacker T, Collier AC, Coombs R, Unadkat JD, Fox I, Alam J, Wang JP, Eggert E, Corey L. Schacker T, et al. Among authors: collier ac. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Jun 1;9(2):145-52. J Acquir Immune Defic Syndr Hum Retrovirol. 1995. PMID: 7749791 Clinical Trial.

7

Combination therapy with zidovudine and didanosine compared with zidovudine alone in HIV-1 infection.

Collier AC, Coombs RW, Fischl MA, Skolnik PR, Northfelt D, Boutin P, Hooper CJ, Kaplan LD, Volberding PA, Davis LG, Henrard DR, Weller S, Corey L. Collier AC, et al. Ann Intern Med. 1993 Oct 15;119(8):786-93. doi: 10.7326/0003-4819-119-8-199310150-00003. Ann Intern Med. 1993. PMID: 8379600 Clinical Trial.

8

Unintegrated circular HIV-1 DNA in the peripheral mononuclear cells of HIV-1-infected subjects: association with high levels of plasma HIV-1 RNA, rapid decline in CD4 count, and clinical progression to AIDS.

Panther LA, Coombs RW, Zeh JE, Collier AC, Corey L. Panther LA, et al. Among authors: collier ac. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Apr 1;17(4):303-13. doi: 10.1097/00042560-199804010-00003. J Acquir Immune Defic Syndr Hum Retrovirol. 1998. PMID: 9525430

9

A randomized controlled trial of a reduced daily dose of zidovudine in patients with the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group.

Fischl MA, Parker CB, Pettinelli C, Wulfsohn M, Hirsch MS, Collier AC, Antoniskis D, Ho M, Richman DD, Fuchs E, et al. Fischl MA, et al. Among authors: collier ac. N Engl J Med. 1990 Oct 11;323(15):1009-14. doi: 10.1056/NEJM199010113231501. N Engl J Med. 1990. PMID: 1977079 Free article. Clinical Trial.

10

Do HIV type 1 RNA levels provide additional prognostic value to CD4(+) T lymphocyte counts in patients with advanced HIV type 1 infection?

Arduino JM, Fischl MA, Stanley K, Collier AC, Spiegelman D. Arduino JM, et al. Among authors: collier ac. AIDS Res Hum Retroviruses. 2001 Aug 10;17(12):1099-105. doi: 10.1089/088922201316912709. AIDS Res Hum Retroviruses. 2001. PMID: 11522179 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

404 results

Search Page

Filters